Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer
Primary prostate tumor heterogeneity is poorly understood, leaving research efforts with challenges regarding the initiation and advancement of the disease. The growth of tumor cells is accompanied by mutations in nuclear and in mitochondrial genomes. Thus, mitochondrial DNA mutations may be used as...
Saved in:
Main Authors: | Christian Arstad, Kristin Taskén, Paulo Refinetti, Ulrika Axcrona, Karl-Erik Giercksky, Per Olaf Ekstrøm |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2020/7673684 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of Somatic Mutations in Malaysian Luminal Breast Cancer
by: Yock Ping Chow, et al.
Published: (2018-12-01) -
Mitochondrial Heterogeneity: Evaluating Mitochondrial Subpopulation Dynamics in Stem Cells
by: D. C. Woods
Published: (2017-01-01) -
Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
by: Andrea Luchetti, et al.
Published: (2015-01-01) -
Validation of Customized Cancer Panel for Detecting Somatic Mutations and Copy Number Alterations
by: Su-Hye Choi, et al.
Published: (2017-12-01) -
Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
by: Gizem Teoman, et al.
Published: (2024-12-01)